ECSP045249A - "NEW INHIBITORS OF FARNESIL PROTEINA TRANSFERASA AS ANTITUMOR AGENTS" - Google Patents
"NEW INHIBITORS OF FARNESIL PROTEINA TRANSFERASA AS ANTITUMOR AGENTS"Info
- Publication number
- ECSP045249A ECSP045249A ECSP045249A ECSP045249A EC SP045249 A ECSP045249 A EC SP045249A EC SP045249 A ECSP045249 A EC SP045249A EC SP045249 A ECSP045249 A EC SP045249A
- Authority
- EC
- Ecuador
- Prior art keywords
- transferasa
- farnesil
- proteina
- antitumor agents
- new inhibitors
- Prior art date
Links
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229950008696 farnesil Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 102000007317 Farnesyltranstransferase Human genes 0.000 abstract 1
- 108010007508 Farnesyltranstransferase Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen compuestos tricíclicos novedosos representados por la fórmula (1.0):y una sal ó solvato de los mismos aceptable para uso farmacéutico. Los compuestos son útiles para inhibir la proteína farnesil transferasa. También se describen composiciones farmacéuticas que comprenden compuestos de fórmula 1.0. También se describen métodos para el tratamiento del cáncer utilizando los compuestos de fórmula 1.0.Novel tricyclic compounds represented by formula (1.0) are described: and a salt or solvate thereof acceptable for pharmaceutical use. The compounds are useful for inhibiting farnesyl transferase protein. Pharmaceutical compositions comprising compounds of formula 1.0 are also described. Methods for the treatment of cancer using the compounds of formula 1.0 are also described.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/085,896 US20030229099A1 (en) | 2000-08-30 | 2002-02-27 | Novel farnesyl protein transferase inhibitors as antitumor agents |
| US10/325,896 US7342016B2 (en) | 2000-08-30 | 2002-12-19 | Farnesyl protein transferase inhibitors as antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045249A true ECSP045249A (en) | 2004-09-28 |
Family
ID=35519530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP045249 ECSP045249A (en) | 2002-02-27 | 2004-08-25 | "NEW INHIBITORS OF FARNESIL PROTEINA TRANSFERASA AS ANTITUMOR AGENTS" |
Country Status (2)
| Country | Link |
|---|---|
| EC (1) | ECSP045249A (en) |
| ZA (1) | ZA200406807B (en) |
-
2004
- 2004-08-25 EC ECSP045249 patent/ECSP045249A/en unknown
- 2004-08-26 ZA ZA200406807A patent/ZA200406807B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200406807B (en) | 2005-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022001357A2 (en) | Pyrazolo[3,4-b]pyrazine-type shp2 phosphatase inhibitors | |
| ECSP066349A (en) | FARNESIL PROTEIN TRANSFER INHIBITORS NOVEDOSOS AS ANTITUMOR AGENTS | |
| AR024060A1 (en) | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| UY29087A1 (en) | ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE | |
| ECSP045004A (en) | INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF DEPENDING ANDROGEN DISEASES | |
| AR045595A1 (en) | USEFUL COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS | |
| PA8591701A1 (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
| PA8583401A1 (en) | NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| ECSP105253A (en) | DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS INHIBITORS OF PI3 CINASA | |
| CO5271715A1 (en) | 7-AZA-INDOLIN-2-WAVES SUBSTITUTED IN 4 AND ITS USE AS PROTEIUNA QUINASA INHIBITORS | |
| PA8583301A1 (en) | NEW IMIDAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| HN2008000949A (en) | PIRIMIDINIL- ARIL- UREA DERIVATIVES THAT ARE FGF INHIBITORS | |
| UY28572A1 (en) | NEW COMPOUNDS | |
| ECSP055640A (en) | PIRAZOL COMPOSITIONS USEFUL AS INHIBITORS OF GSK-3 | |
| UY29370A1 (en) | DERIVATIVES OF TIAZOL, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURES AND APPLICATIONS | |
| CR7743A (en) | NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| SE0302192D0 (en) | Novel compounds | |
| PA8495101A1 (en) | DERIVATIVES OF 13-METHYLERITROMYCIN | |
| GT200600161A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS | |
| PA8561501A1 (en) | LACTAMAS AS TAQUIQUININE ANTAGONISTS | |
| UY26920A1 (en) | 7 - PYRIDOPIRIMIDIN OXY | |
| ECSP034494A (en) | NEW INHIBITORS OF FARNESIL PROTEINO TRASFERASA AS ANTITUMOR AGENTS | |
| BR0308071A (en) | Farnesyl transferase protein inhibitors as anti-smoking agents | |
| ATE302203T1 (en) | PYRAZOLOPYRIMIDINE AND PYRAZOLOTRIAZINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | |
| UY28377A1 (en) | THERAPEUTIC AGENTS |